These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18497549)

  • 21. Serum tumour markers in gynaecological cancers.
    Aggarwal P; Kehoe S
    Maturitas; 2010 Sep; 67(1):46-53. PubMed ID: 20510555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.
    Mangili G; Sigismondi C; Lorusso D; Cormio G; Candiani M; Scarfone G; Mascilini F; Gadducci A; Mosconi AM; Scollo P; Cassani C; Pignata S; Ferrandina G
    Ann Oncol; 2017 Feb; 28(2):333-338. PubMed ID: 27803008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterization of 2 testicular germ cell markers, Glut3 and CyclinA2.
    Howitt BE; Brooks JD; Jones S; Higgins JP
    Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):401-7. PubMed ID: 23343953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian malignant mixed germ cell tumor with clear cell carcinoma in a postmenopausal woman.
    Yu XJ; Zhang L; Liu ZP; Shi YQ; Liu YX
    Int J Clin Exp Pathol; 2014; 7(12):8996-9001. PubMed ID: 25674278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignant ovarian germ cell tumors: a single-institution experience.
    Cicin I; Eralp Y; Saip P; Ayan I; Kebudi R; Iyibozkurt C; Tuzlali S; Gorgun O; Topuz E
    Am J Clin Oncol; 2009 Apr; 32(2):191-6. PubMed ID: 19307952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnosis of germinogenic ovarian tumors in girls].
    Nechushkina IV; Koshechkina NA; Kharitonova TV; Baturin NIu
    Vestn Ross Akad Med Nauk; 2000; (6):5-8. PubMed ID: 10943151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mixed ovarian germ cell tumor composed of immature teratoma, yolk sac tumor and embryonal carcinoma.
    Wang Y; Zhou F; Qian Z; Qing J; Zhao M; Huang L
    J Coll Physicians Surg Pak; 2014 Nov; 24 Suppl 3():S198-200. PubMed ID: 25518772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours.
    Murray MJ; Bell E; Raby KL; Rijlaarsdam MA; Gillis AJ; Looijenga LH; Brown H; Destenaves B; Nicholson JC; Coleman N
    Br J Cancer; 2016 Jan; 114(2):151-62. PubMed ID: 26671749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor markers CA 125 and CA 19-9 in cord blood and during infancy: developmental changes and use in pediatric germ cell tumors.
    Lahdenne P; Pitkänen S; Rajantie J; Kuusela P; Siimes MA; Lanning M; Heikinheimo M
    Pediatr Res; 1995 Nov; 38(5):797-801. PubMed ID: 8552451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphologic, immunohistochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma.
    Cheng L; Zhang S; Talerman A; Roth LM
    Hum Pathol; 2010 May; 41(5):716-23. PubMed ID: 20096442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers.
    Hoei-Hansen CE; Kraggerud SM; Abeler VM; Kaern J; Rajpert-De Meyts E; Lothe RA
    Mol Cancer; 2007 Feb; 6():12. PubMed ID: 17274819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.
    Cao D; Guo S; Allan RW; Molberg KH; Peng Y
    Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors.
    Looijenga LH; Stoop H; de Leeuw HP; de Gouveia Brazao CA; Gillis AJ; van Roozendaal KE; van Zoelen EJ; Weber RF; Wolffenbuttel KP; van Dekken H; Honecker F; Bokemeyer C; Perlman EJ; Schneider DT; Kononen J; Sauter G; Oosterhuis JW
    Cancer Res; 2003 May; 63(9):2244-50. PubMed ID: 12727846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards a non-invasive method for early detection of testicular neoplasia in semen samples by identification of fetal germ cell-specific markers.
    Hoei-Hansen CE; Carlsen E; Jorgensen N; Leffers H; Skakkebaek NE; Rajpert-De Meyts E
    Hum Reprod; 2007 Jan; 22(1):167-73. PubMed ID: 16920726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
    Kobayashi T; Kawakita M; Terachi T; Habuchi T; Ogawa O; Kamoto T
    J Surg Oncol; 2006 Dec; 94(7):619-23. PubMed ID: 17111392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic utility of novel stem cell markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in primary mediastinal germ cell tumors.
    Liu A; Cheng L; Du J; Peng Y; Allan RW; Wei L; Li J; Cao D
    Am J Surg Pathol; 2010 May; 34(5):697-706. PubMed ID: 20410807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistently elevated alpha-fetoprotein associated with chronic hepatitis B during chemotherapy for malignant ovarian germ cell tumors: a case series and a review of the literature.
    Zong X; Yang JX; Zhang Y
    J Ovarian Res; 2019 Dec; 12(1):124. PubMed ID: 31836006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated serum levels of IGF-binding protein 2 in patients with non-seminomatous germ cell cancer: correlation with tumor markers alpha-fetoprotein and human chorionic gonadotropin.
    Fottner C; Sattarova S; Hoffmann K; Spöttl G; Weber MM
    Eur J Endocrinol; 2008 Sep; 159(3):317-27. PubMed ID: 18524796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
    Yang ZJ; Liu ZC; Wei RJ; Li L
    Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors.
    Cao D; Humphrey PA; Allan RW
    Cancer; 2009 Jun; 115(12):2640-51. PubMed ID: 19365862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.